Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |